Stocks
Fate Therapeutics (FATE) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.02 | 3.07 | 2.32 | 1.06 | 1.33 | 1.42 | |||
| Changes by years, y/y, % | -30% | +52% | -24% | -54% | +25% | -14.3% | |||
Fate Therapeutics. Debt/EBITDA
Fate Therapeutics. Debt/EBITDA, changes, %
Fate Therapeutics (FATE) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 1.19 | 1.18 | 1.24 | 1.20 | 1.42 | 1.42 | ||
| Changes by years, y/y, % | -39% | -33% | -6% | +10% | +18% | |||
| Changes by quarters, q/q, % | +9% | -1% | +5% | -3% | +18% | |||
